368 related articles for article (PubMed ID: 22268294)
21. TGF-β autocrine pathway and MAPK signaling promote cell invasiveness and in vivo mammary adenocarcinoma tumor progression.
Daroqui MC; Vazquez P; Bal de Kier Joffé E; Bakin AV; Puricelli LI
Oncol Rep; 2012 Aug; 28(2):567-75. PubMed ID: 22614218
[TBL] [Abstract][Full Text] [Related]
22. Autocrine PDGFR signaling promotes mammary cancer metastasis.
Jechlinger M; Sommer A; Moriggl R; Seither P; Kraut N; Capodiecci P; Donovan M; Cordon-Cardo C; Beug H; Grünert S
J Clin Invest; 2006 Jun; 116(6):1561-70. PubMed ID: 16741576
[TBL] [Abstract][Full Text] [Related]
23. Grb2 binding to Tyr284 in TbetaR-II is essential for mammary tumor growth and metastasis stimulated by TGF-beta.
Galliher-Beckley AJ; Schiemann WP
Carcinogenesis; 2008 Feb; 29(2):244-51. PubMed ID: 18174260
[TBL] [Abstract][Full Text] [Related]
24. Lack of transforming growth factor-β signaling promotes collective cancer cell invasion through tumor-stromal crosstalk.
Matise LA; Palmer TD; Ashby WJ; Nashabi A; Chytil A; Aakre M; Pickup MW; Gorska AE; Zijlstra A; Moses HL
Breast Cancer Res; 2012 Jul; 14(4):R98. PubMed ID: 22748014
[TBL] [Abstract][Full Text] [Related]
25. Transforming growth factor-β signaling in tumor initiation, progression and therapy in breast cancer: an update.
Zu X; Zhang Q; Cao R; Liu J; Zhong J; Wen G; Cao D
Cell Tissue Res; 2012 Jan; 347(1):73-84. PubMed ID: 21845401
[TBL] [Abstract][Full Text] [Related]
26. Activated Abl kinase inhibits oncogenic transforming growth factor-beta signaling and tumorigenesis in mammary tumors.
Allington TM; Galliher-Beckley AJ; Schiemann WP
FASEB J; 2009 Dec; 23(12):4231-43. PubMed ID: 19690215
[TBL] [Abstract][Full Text] [Related]
27. Src phosphorylates Tyr284 in TGF-beta type II receptor and regulates TGF-beta stimulation of p38 MAPK during breast cancer cell proliferation and invasion.
Galliher AJ; Schiemann WP
Cancer Res; 2007 Apr; 67(8):3752-8. PubMed ID: 17440088
[TBL] [Abstract][Full Text] [Related]
28. Enhanced hepatocyte growth factor signaling by type II transforming growth factor-beta receptor knockout fibroblasts promotes mammary tumorigenesis.
Cheng N; Chytil A; Shyr Y; Joly A; Moses HL
Cancer Res; 2007 May; 67(10):4869-77. PubMed ID: 17495323
[TBL] [Abstract][Full Text] [Related]
29. Metabolic reprogramming of cancer-associated fibroblasts by TGF-β drives tumor growth: connecting TGF-β signaling with "Warburg-like" cancer metabolism and L-lactate production.
Guido C; Whitaker-Menezes D; Capparelli C; Balliet R; Lin Z; Pestell RG; Howell A; Aquila S; Andò S; Martinez-Outschoorn U; Sotgia F; Lisanti MP
Cell Cycle; 2012 Aug; 11(16):3019-35. PubMed ID: 22874531
[TBL] [Abstract][Full Text] [Related]
30. The relevance of the TGF-β Paradox to EMT-MET programs.
Morrison CD; Parvani JG; Schiemann WP
Cancer Lett; 2013 Nov; 341(1):30-40. PubMed ID: 23474494
[TBL] [Abstract][Full Text] [Related]
31. Breast fibroblasts modulate early dissemination, tumorigenesis, and metastasis through alteration of extracellular matrix characteristics.
Dumont N; Liu B; Defilippis RA; Chang H; Rabban JT; Karnezis AN; Tjoe JA; Marx J; Parvin B; Tlsty TD
Neoplasia; 2013 Mar; 15(3):249-62. PubMed ID: 23479504
[TBL] [Abstract][Full Text] [Related]
32. X-linked inhibitor of apoptosis protein and its E3 ligase activity promote transforming growth factor-{beta}-mediated nuclear factor-{kappa}B activation during breast cancer progression.
Neil JR; Tian M; Schiemann WP
J Biol Chem; 2009 Aug; 284(32):21209-17. PubMed ID: 19531477
[TBL] [Abstract][Full Text] [Related]
33. Attenuation of TGF-β signaling suppresses premature senescence in a p21-dependent manner and promotes oncogenic Ras-mediated metastatic transformation in human mammary epithelial cells.
Lin S; Yang J; Elkahloun AG; Bandyopadhyay A; Wang L; Cornell JE; Yeh IT; Agyin J; Tomlinson G; Sun LZ
Mol Biol Cell; 2012 Apr; 23(8):1569-81. PubMed ID: 22357622
[TBL] [Abstract][Full Text] [Related]
34. Chamaejasmenin B, a novel candidate, inhibits breast tumor metastasis by rebalancing TGF-beta paradox.
Li Q; Wang Y; Xiao H; Li Y; Kan X; Wang X; Zhang G; Wang Z; Yang Q; Chen X; Weng X; Chen Y; Zhou B; Guo Y; Liu X; Zhu X
Oncotarget; 2016 Jul; 7(30):48180-48192. PubMed ID: 27374079
[TBL] [Abstract][Full Text] [Related]
35. Loss of transforming growth factor-beta signaling in mammary fibroblasts enhances CCL2 secretion to promote mammary tumor progression through macrophage-dependent and -independent mechanisms.
Hembruff SL; Jokar I; Yang L; Cheng N
Neoplasia; 2010 May; 12(5):425-33. PubMed ID: 20454514
[TBL] [Abstract][Full Text] [Related]
36. TGF-beta1 and Ha-Ras collaborate in modulating the phenotypic plasticity and invasiveness of epithelial tumor cells.
Oft M; Peli J; Rudaz C; Schwarz H; Beug H; Reichmann E
Genes Dev; 1996 Oct; 10(19):2462-77. PubMed ID: 8843198
[TBL] [Abstract][Full Text] [Related]
37. Transcriptional cooperation between the transforming growth factor-beta and Wnt pathways in mammary and intestinal tumorigenesis.
Labbé E; Lock L; Letamendia A; Gorska AE; Gryfe R; Gallinger S; Moses HL; Attisano L
Cancer Res; 2007 Jan; 67(1):75-84. PubMed ID: 17210685
[TBL] [Abstract][Full Text] [Related]
38. MicroRNA-455-3p mediates GATA3 tumor suppression in mammary epithelial cells by inhibiting TGF-β signaling.
Zeng Y; Gao T; Huang W; Yang Y; Qiu R; Hou Y; Yu W; Leng S; Feng D; Liu W; Teng X; Yu H; Wang Y
J Biol Chem; 2019 Oct; 294(43):15808-15825. PubMed ID: 31492753
[TBL] [Abstract][Full Text] [Related]
39. Transforming growth factor-β-induced epithelial-mesenchymal transition facilitates epidermal growth factor-dependent breast cancer progression.
Wendt MK; Smith JA; Schiemann WP
Oncogene; 2010 Dec; 29(49):6485-98. PubMed ID: 20802523
[TBL] [Abstract][Full Text] [Related]
40. Attenuation of TGF-β signaling supports tumor progression of a mesenchymal-like mammary tumor cell line in a syngeneic murine model.
Biswas T; Gu X; Yang J; Ellies LG; Sun LZ
Cancer Lett; 2014 Apr; 346(1):129-38. PubMed ID: 24368187
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
